LTFS
CORT icon

Ladenburg Thalmann Financial Services’s Corcept Therapeutics CORT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$16K Buy
1,300
+1,110
+584% +$15.5K ﹤0.01% 4245
2019
Q3 		$3K Sell
190
-143
-43% -$1.76K ﹤0.01% 4835
2019
Q2 		$4K Hold
333
– – ﹤0.01% 4765
2019
Q1 		$4K Sell
333
-2,361
-88% -$29.3K ﹤0.01% 4725
2018
Q4 		$37K Buy
2,694
+569
+27% +$7.52K ﹤0.01% 3462
2018
Q3 		$29K Sell
2,125
-705
-25% -$9.85K ﹤0.01% 3656
2018
Q2 		$46K Hold
2,830
– – ﹤0.01% 3310
2018
Q1 		$46K Buy
2,830
+1,289
+84% +$23.9K ﹤0.01% 3310
2017
Q4 		$28K Buy
1,541
+713
+86% +$12.9K ﹤0.01% 3584
2017
Q3 		$16K Buy
828
+641
+343% +$9.56K ﹤0.01% 3806
2017
Q2 		$2K Sell
187
-600
-76% -$6.52K ﹤0.01% 4581
2017
Q1 		$9K Sell
787
-963
-55% -$8.46K ﹤0.01% 4039
2016
Q4 		$13K Buy
+1,750
New +$13.7K ﹤0.01% 3728

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CORT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Corcept Therapeutics (CORT) stake by 584% in Q4 2019, buying an estimated $15.5K and bringing the position to 1,300 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4245.

Ladenburg Thalmann Financial Services first reported a position in CORT in Q4 2016 and has held it in 13 quarters since. The position peaked at $46K in Q2 2018. 205 funds tracked by Wall St. Rank hold CORT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,300 shares of Corcept Therapeutics worth $16K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 1,110 Corcept Therapeutics shares in Q4 2019, an estimated $15.5K.
  • Corcept Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4245 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Corcept Therapeutics in Q4 2016 and has held it in 13 quarters since.
  • Ladenburg Thalmann Financial Services's Corcept Therapeutics position peaked at $46K in Q2 2018.
  • 205 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.